A detailed history of Beese Fulmer Investment Management, Inc. transactions in Pfizer Inc stock. As of the latest transaction made, Beese Fulmer Investment Management, Inc. holds 55,066 shares of PFE stock, worth $1.45 Million. This represents 0.14% of its overall portfolio holdings.

Number of Shares
55,066
Previous 55,284 0.39%
Holding current value
$1.45 Million
Previous $1.55 Million 3.04%
% of portfolio
0.14%
Previous 0.14%

Shares

26 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 22, 2024

SELL
$27.7 - $31.39 $6,038 - $6,843
-218 Reduced 0.39%
55,066 $1.59 Million
Q2 2024

Jul 03, 2024

SELL
$25.26 - $29.6 $110,941 - $130,003
-4,392 Reduced 7.36%
55,284 $1.55 Million
Q1 2024

Apr 08, 2024

SELL
$25.89 - $29.73 $162,718 - $186,853
-6,285 Reduced 9.53%
59,676 $1.66 Million
Q4 2023

Jan 09, 2024

SELL
$26.13 - $33.94 $159,732 - $207,475
-6,113 Reduced 8.48%
65,961 $1.9 Million
Q3 2023

Oct 10, 2023

SELL
$32.09 - $37.51 $33,919 - $39,648
-1,057 Reduced 1.45%
72,074 $2.39 Million
Q2 2023

Jul 11, 2023

SELL
$36.12 - $41.79 $99,257 - $114,838
-2,748 Reduced 3.62%
73,131 $2.68 Million
Q1 2023

Apr 11, 2023

SELL
$39.39 - $51.28 $90,715 - $118,097
-2,303 Reduced 2.95%
75,879 $3.1 Million
Q4 2022

Jan 17, 2023

SELL
$41.75 - $54.5 $6,053 - $7,902
-145 Reduced 0.19%
78,182 $0
Q3 2022

Oct 06, 2022

BUY
$43.76 - $53.42 $51,986 - $63,462
1,188 Added 1.54%
78,327 $3.43 Million
Q2 2022

Jul 11, 2022

BUY
$46.53 - $55.17 $3,070 - $3,641
66 Added 0.09%
77,139 $4.04 Million
Q1 2022

Apr 12, 2022

SELL
$45.75 - $56.69 $223,397 - $276,817
-4,883 Reduced 5.96%
77,073 $3.99 Million
Q4 2021

Jan 10, 2022

SELL
$41.32 - $61.25 $45,865 - $67,987
-1,110 Reduced 1.34%
81,956 $4.84 Million
Q3 2021

Oct 08, 2021

SELL
$39.25 - $50.42 $23,707 - $30,453
-604 Reduced 0.72%
83,066 $3.57 Million
Q2 2021

Jul 08, 2021

BUY
$35.91 - $40.68 $11,778 - $13,343
328 Added 0.39%
83,670 $3.28 Million
Q1 2021

Apr 23, 2021

BUY
$33.49 - $37.77 $29,069 - $32,784
868 Added 1.05%
83,342 $3.02 Million
Q4 2020

Jan 20, 2021

BUY
$33.47 - $42.56 $25,303 - $32,175
756 Added 0.93%
82,474 $3.04 Million
Q3 2020

Oct 08, 2020

SELL
$31.75 - $37.25 $169,576 - $198,952
-5,341 Reduced 6.13%
81,718 $3 Million
Q2 2020

Jul 17, 2020

SELL
$30.12 - $36.54 $24,126 - $29,268
-801 Reduced 0.91%
87,059 $2.85 Million
Q1 2020

Apr 09, 2020

SELL
$27.03 - $38.62 $39,490 - $56,423
-1,461 Reduced 1.64%
87,860 $2.87 Million
Q4 2019

Feb 05, 2020

SELL
$32.92 - $37.36 $158,180 - $179,514
-4,805 Reduced 5.1%
89,321 $3.5 Million
Q3 2019

Nov 01, 2019

BUY
$32.49 - $42.13 $1.15 Million - $1.5 Million
35,488 Added 60.52%
94,126 $3.38 Million
Q4 2018

Jan 25, 2019

SELL
$38.47 - $43.86 $11,541 - $13,158
-300 Reduced 0.51%
58,638 $2.56 Million
Q3 2018

Oct 09, 2018

BUY
$34.47 - $41.81 $10,341 - $12,543
300 Added 0.51%
58,938 $2.6 Million
Q1 2018

Apr 16, 2018

SELL
$31.91 - $37.02 $15,380 - $17,843
-482 Reduced 0.82%
58,638 $2.08 Million
Q4 2017

Jan 26, 2018

SELL
$33.26 - $35.29 $56,874 - $60,345
-1,710 Reduced 2.81%
59,120 $2.14 Million
Q3 2017

Oct 17, 2017

BUY
$31.0 - $34.15 $1.89 Million - $2.08 Million
60,830
60,830 $2.17 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Beese Fulmer Investment Management, Inc. Portfolio

Follow Beese Fulmer Investment Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Beese Fulmer Investment Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Beese Fulmer Investment Management, Inc. with notifications on news.